• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (OP:AIMN)

    0.0070 +0.0006 (+9.37%)
    Streaming Delayed Price Updated: 2:53 PM EDT, Jul 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about AIMN

    News headline image
    Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence
    From Aimwell Partners
    Via ACCESS Newswire
    News headline image
    AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost
    Via ACCESS Newswire
    News headline image
    The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know?
    Via ACCESS Newswire
    News headline image
    As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It
    Via ACCESS Newswire
    News headline image
    AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In
    Via ACCESS Newswire
    News headline image
    Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself
    Via ACCESS Newswire
    News headline image
    The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI
    Via ACCESS Newswire
    News headline image
    Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians
    Via ACCESS Newswire
    News headline image
    The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For.
    Via ACCESS Newswire
    News headline image
    Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones
    Via ACCESS Newswire
    News headline image
    While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t.
    Via ACCESS Newswire
    News headline image
    AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
    Via ACCESS Newswire
    News headline image
    AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings
    Via ACCESS Newswire
    News headline image
    Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure
    Via ACCESS Newswire
    News headline image
    Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma
    Via ACCESS Newswire
    News headline image
    AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio
    Via ACCESS Newswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.